iBio, Inc. — Director's Dealing 2017

Apr 5, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2017-03-01

Reporting Person: Mullaney James P. (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.40	2027-03-01	Common Stock (150000)		Direct

Footnotes

F1: Vests in three equal annual installments beginning on the first anniversary of the date of grant.